Advertisement

Skin of Color pp 247-262 | Cite as

Dermal Fillers in Ethnic Skin

  • Cheryl M. Burgess
Chapter

Abstract

Growth in the ethnic patient population has been driven by growing diversity of skin types and shifting trends in US demographics. In addition, products and procedures that target the ethnic market are also bringing more ethnic patients into the clinic. Moreover, nearly one-third of ethnic patents indicated in a recent survey that they would consider having cosmetic surgery and many cosmetic surgeries are being performed in ethnic patients. According to recent surveys, 13 million cosmetic procedures were performed in 2010, an overall increase of 110% in minimally invasive procedures since 2000.

Keywords

Human Immunodeficiency Virus Hyaluronic Acid Cosmetic Surgery Calcium Hydroxyapatite Cosmetic Procedure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    American Society for Aesthetic Surgery: Cosmetic surgery National Data Bank statistics. Available at: www.surgery.org/download/2005stats.pdf (2005). Accessed 24 Aug 2006.
  2. 2.
    American Society for Aesthetic Surgery: Cosmetic surgery National Data Bank statistics. Available at: www.surgery.org/download/2008stats.pdf (2008). Accessed 20 July 2009.
  3. 3.
    Vleggaar D, Fitzgerald R. Dermatological implications of skeletal aging: a focus on supraperiosteal volumization for perioral rejuvenation. J Drugs Dermatol. 2008;7(3):209–20.PubMedGoogle Scholar
  4. 4.
    Donofrio LM. Fat distribution: a morphologic study of the aging face. Dermatol Surg. 2000;26(12):1107–12.PubMedCrossRefGoogle Scholar
  5. 5.
    Alster T, Jorizzo J, Hanke W, Weinkle S, Werschler P. The aging face: more than skin deep CME. Available at: http://www.medscape.org/viewprogram/3401
  6. 6.
    Lupton JR, Alster TS. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg. 2000;26(2):135–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Klein AW, Elson ML. The history of substances for soft tissue augmentation. Dermatol Surg. 2000;26(12):1096–105.PubMedCrossRefGoogle Scholar
  8. 8.
    Burgess C. Soft tissue augmentation. In: Burgess C, editor. Cosmetic dermatology. Heidelberg: Springer; 2005. p. 93–110.CrossRefGoogle Scholar
  9. 9.
    Lowe NJ, et al. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol. 2001;45(6):930–3.PubMedCrossRefGoogle Scholar
  10. 10.
    Taylor SC, Burgess CM, Callender VD. Safety of nonanimal stabilized hyaluronic acid dermal fillers in patients with skin of color: a randomized, evaluator-blinded comparative trial. Dermatol Surg. 2009;35 Suppl 2:1653–60.PubMedCrossRefGoogle Scholar
  11. 11.
    Hamilton T. Skin augmentation and correction: the new generation of dermal fillers-a dermatologist’s experience. Clin Dermatol. 2009;27:13–22.CrossRefGoogle Scholar
  12. 12.
    DAAI. Legal and regulatory issues regarding new-Fill. Resources DAAI, Inc; 2001.Google Scholar
  13. 13.
    Beljaards RC, de Roos KP, Bruins FG. NewFill for skin augmentation: a new filler or failure? Dermatol Surg. 2005;31(7 Pt 1):772–6.PubMedGoogle Scholar
  14. 14.
    Saylan Z. Facial fillers and their complications. Aesthet Surg J. 2003;23:221–4.PubMedCrossRefGoogle Scholar
  15. 15.
    Dreschnack P, Farber G. Complications of Sculptra for cosmetic skin contour enhancements. Am J Cosmet Dermatol. 2007;24(3):143–5.Google Scholar
  16. 16.
    Werschler W, Bondar G, Esch P. Six simple steps to Sculptra success: expert advice for incorporating this new filler agent into your practice. Skin and Aging. 2005;13(1):56–64.Google Scholar
  17. 17.
    Burgess C, Lowe N. Letter to the editor: regarding “NewFill” for skin augmentation: a new filler or failure? Dermatol Surg. 2006;32:1530–2. author reply 1530–2.PubMedCrossRefGoogle Scholar
  18. 18.
    Vleggaar D, Bauer U. Facial enhancement and the European experience with Sculptra (poly-l-lactic acid). J Drugs Dermatol. 2004;3(5):542–7.PubMedGoogle Scholar
  19. 19.
    Anonymous. Questions and answers: ASCDAS 3rd annual meeting. New options in the recognition and treatment of lipoatrophy with volume restoration. Cosmet Dermatol. 2005;18(3):235–9.Google Scholar
  20. 20.
    Burgess CM. Soft tissue augmentation in skin of color: market growth, available fillers, and successful techniques. J Drugs Dermatol. 2007;6(1):51–5.PubMedGoogle Scholar
  21. 21.
    Carruthers A, Kiene K, Carruthers J. Botulinum A exotoxin use in clinical dermatology. J Am Acad Dermatol. 1996;34(5 Pt 1):788–97.PubMedCrossRefGoogle Scholar
  22. 22.
    Sadick NS, Karcher C, Palmisano L. Cosmetic dermatology of the aging face. Clin Dermatol. 2009;27:3–12.CrossRefGoogle Scholar
  23. 23.
    Ascher B, Coleman S, Alster T, et al. Full scope of effect of facial lipoatrophy: a framework of disease understanding. Dermatol Surg. 2006;32(8):1058–69.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of DermatologyGeorgetown University Medical Center, George Washington University, Center for Dermatology and Dermatologic SurgeryWashingtonUSA

Personalised recommendations